Your cat was diagnosed with Primary Pulmonary Carcinoma. 90% are adenocarcinomas. 75% metastatic at diagnosis. Includes LUNG-DIGIT SYNDROME — a unique feline metastatic pattern where primary pulmonary carcinoma metastasises to the digits. The digit swelling may be the FIRST clinical sign noticed before the lung tumour is discovered. MST 67 days (Goldfinch & Argyle 2012). Diagnostic pathway: any cat with digit swelling → thoracic radiographs. Common in older cats. ENVIRONMENTAL RISK: Second-hand tobacco smoke exposure associated with increased risk (Bertone et al. 2002, PMID 12023141). Compare 5 treatment options for cats including Lung Lobectomy, Chemotherapy (Carboplatin or Mitoxantrone), Toceranib (Off-Label) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Primary Pulmonary Carcinoma
Feline Oncology Treatment Guide
Primary Pulmonary Carcinoma
Epithelial
About This Cancer
Primary lung cancer in cats is most commonly an adenocarcinoma arising from the cells lining the airways or air sacs. A distinctive feature of feline lung cancer is its high rate of metastasis at the time of diagnosis — a high proportion of cats already have evidence of spread at the time of diagnosis. A particularly unusual metastatic pattern is the 'lung-digit syndrome,' in which the cancer spreads to the toes, causing swelling of one or more digits — sometimes the toe swelling is actually noticed before the lung tumour is discovered. Cats with solitary lung masses that have not yet spread can benefit from surgical lung lobectomy, but the high rate of advanced disease at diagnosis means that many cats are not surgical candidates. The disease mainly affects older cats, and symptoms include coughing, difficulty breathing, and weight loss.
Practical Staging for Feline Primary Pulmonary Carcinoma
No formal validated TNM system. Practical staging based on resectability and extent.
Prognostic Factors(6)
Minimum Workup(7 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.